Really? Anyone know about this case? On January 13, 2003, Pellet Technologies and Martin Avenue Pharmacy entered into a non-exclusive license agreement (“License Agreement”) wherein Martin Avenue Pharmacy would compound pellets containing naltrexone and other chemicals pursuant to the ‘813 Patent. 13.

Read this civil complaint regarding a compounding pharmacy and a doctor,

PELLET TECHNOLOGIES, LLC, and LANCE L. GOOBERMAN :

v. MARTIN AVENUE PHARMACY, INC. :

and THOMAS MARKS 


This article states Dr. Gooberman developed the pellet technologies with Wedgewood Pharmacy.  Read here

Read this account here  


SUPERIOR COURT OF NEW JERSEY
APPELLATE DIVISION
DOCKET NO. A-1887-99T3
JANE DARWIN,See footnote 11
Plaintiff-Appellant,
v.
LANCE L. GOOBERMAN, M.D.,
and JOHN DOE,
Defendant-Respondent.
_______________________________
Submitted: February 7, 2001 - Decided: March 5, 2001